SHH · —

Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS) Stock

$20.65 -2.73% SHH: 600285.SS —

—

Valuation

Metric	Value
Price	$20.65
Market Cap	$10.79B
P/E Ratio	13.79
P/B Ratio	3.34
P/S Ratio	2.77
EPS (TTM)	$1.37
52-Week High	$23.65
52-Week Low	$18.51
Dividend Yield	5.70%

Financials & Margins

Metric	Value
ROE	24.63%
ROA	9.42%
ROCE	—
Gross Margin	78.63%
Operating Margin	27.03%
Net Margin	19.99%
Debt/Equity	0.13
Current Ratio	1.18

Latest News

Argo points to swelling disorder drug’s differentiated profile on Phase II success Clinical Trials Arena · Sep 4, 2026 S&P Global Ratings Upgrades Teva to BBB-, Marking Third Credit Rating Upgrade in Recent Months and Reflecting Strong Execution and Financial Discipline GlobeNewswire · Sep 4, 2026 New Poll: Parents Overwhelmingly Support the Agreement Between the States & Meta To Keep Young People Safe Online PR Newswire · Sep 4, 2026 The Hidden Costs of Retiring in Las Vegas Nobody Mentions Until the First Summer 24/7 Wall St. · Sep 4, 2026 Thousand Trails' TrailBlazer Magazine Honored with 2026 GDUSA Inhouse Design Award PR Newswire · Sep 4, 2026

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	10.20
FCF Yield	—
Quick Ratio	1.02
Interest Coverage	—
Return 1Y	-5.20%
Return 3Y	41.89%
Return 5Y	149.97%

Ownership

Insiders Held24.02%

Institutions Held11.41%

Institutions Float Held15.01%

About Henan Lingrui Pharmaceutical Co., Ltd.

—

Henan Lingrui Pharmaceutical Co., Ltd. is led by CEO Wei Xiong, employs 2,789 people, headquartered in Xinyang, CN, publicly traded since 2000.

Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS) stock trades at $20.65 with a market capitalization of $10.79B. The stock is valued at a price-to-earnings (P/E) ratio of 13.79, price-to-book of 3.34, price-to-sales of 2.77. Over the past 52 weeks the stock has ranged between $18.51 and $23.65, and currently trades 12.7% below its 52-week high. It pays a dividend yielding 5.70%.

On profitability, Henan Lingrui Pharmaceutical Co., Ltd. generates a return on equity (ROE) of 24.63%, above the typical market range of roughly 12-15%, an operating margin of 27.03%, a net profit margin of 19.99%.

Official website: www.lingrui.com

Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS) — frequently asked questions

What is Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS) stock price today?

Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS) is currently trading at $20.65, down 2.73% today.

What is 600285.SS P/E ratio?

Henan Lingrui Pharmaceutical Co., Ltd.'s P/E ratio is 13.79. This is below the typical market average of roughly 18-22x. A low P/E can reflect a lower valuation, slower expected growth, or both.

What is 600285.SS return on equity (ROE)?

Henan Lingrui Pharmaceutical Co., Ltd.'s return on equity (ROE) is 24.63%. ROE measures net income relative to shareholders' equity. This is above the typical market range of roughly 12-15%.

What is Henan Lingrui Pharmaceutical Co., Ltd.'s market cap?

Henan Lingrui Pharmaceutical Co., Ltd. has a market capitalization of $10.79B.

Does 600285.SS pay a dividend?

Yes. Henan Lingrui Pharmaceutical Co., Ltd. currently yields 5.70%. Yield moves with the share price, so it changes daily even when the payment does not.

How much debt does 600285.SS carry?

Henan Lingrui Pharmaceutical Co., Ltd. has a debt-to-equity ratio of 0.13. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is 600285.SS's profit margin?

Henan Lingrui Pharmaceutical Co., Ltd. reports a net profit margin of 19.99% — the share of revenue left after every cost, including tax and interest.

What sector is 600285.SS in?

Henan Lingrui Pharmaceutical Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is 600285.SS listed on?

Henan Lingrui Pharmaceutical Co., Ltd. trades on SHH under the ticker 600285.SS.

What is 600285.SS's 52-week range?

Over the last year Henan Lingrui Pharmaceutical Co., Ltd. has traded between $18.51 and $23.65.

Related — Stocks

BSP Bending Spoons S.p.A. $45.72 +3.72% MAIR Madison Air Solutions Corporation $22.86 +0.44% USDE StablecoinX Inc. $1.00 -0.01% LFTO Liftoff Mobile, Inc. $16.75 +3.01% LYCA Lycia Therapeutics, Inc. $28.85 +1.05% HBNB Hotel101 Global Holdings Corp. $4.98 +3.21% LCLN Lincoln International, Inc. $23.44 +0.77% BLSM BlossomHill Therapeutics, Inc. $16.39 +15.75% FCBM First Carolina Financial Services, Inc. $12.93 +3.44% EFTY Etoiles Capital Group Co., Ltd. $15.02 +0.00% BGM BGM Group Ltd. $8.40 -6.35% HCHL Happy City Holdings Limited $3.96 +0.00%

Screens 600285.SS currently matches

On the figures above, Henan Lingrui Pharmaceutical Co., Ltd. passes the filters for 22 of our ready-made screens, among them Undervalued Large Cap Stocks, Undervalued Dividend Stocks, High Dividend Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Undervalued Large Cap Stocks Undervalued Dividend Stocks High Dividend Stocks Dividend Stocks Low Debt Dividend Stocks High ROE Stocks Low Debt Stocks Low Debt High ROE Stocks Large Cap Stocks Stocks With Insider Buying Stock Screener Starter Free Stock Screener Picks Stocks With PE Under 20 High Dividend Low PE Stocks Large Cap High Dividend Stocks Low PE Stocks Yielding Over 5%Dividend Yield Over 5%High Margin Dividend Stocks Stocks Under $100 Stocks Under $50 High Gross Margin Stocks Low PE High ROE Stocks

Related stock screens

High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks All stock screens

Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.